These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1838107)

  • 1. PAF antagonists inhibit monocrotaline-induced lung injury and pulmonary hypertension.
    Ono S; Voelkel NF
    J Appl Physiol (1985); 1991 Dec; 71(6):2483-92. PubMed ID: 1838107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lung 3H-thymidine incorporation in monocrotaline (MCT)-treated rats--role of platelet-activating factor (PAF)].
    Ono S; Tanita T; Ashino Y; Noda M; Tabata S; Hoshikawa Y; Ueda S; Nishimura T; Fujimura S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 May; 32(5):441-5. PubMed ID: 8084100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAF receptor blockade inhibits lung vascular changes in the rat monocrotaline model.
    Ono S; Voelkel NF
    Lung; 1992; 170(1):31-40. PubMed ID: 1310128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline.
    Voelkel NF; Tuder RM; Bridges J; Arend WP
    Am J Respir Cell Mol Biol; 1994 Dec; 11(6):664-75. PubMed ID: 7946395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PAF antagonists inhibit pulmonary vascular remodeling induced by hypobaric hypoxia in rats.
    Ono S; Westcott JY; Voelkel NF
    J Appl Physiol (1985); 1992 Sep; 73(3):1084-92. PubMed ID: 1400021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonspecific endothelin-receptor antagonist blunts monocrotaline-induced pulmonary hypertension in rats.
    Hill NS; Warburton RR; Pietras L; Klinger JR
    J Appl Physiol (1985); 1997 Oct; 83(4):1209-15. PubMed ID: 9338430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnesium aspartate hydrochloride attenuates monocrotaline-induced pulmonary artery hypertension in rats.
    Mathew R; Gloster ES; Altura BT; Altura BM
    Clin Sci (Lond); 1988 Dec; 75(6):661-7. PubMed ID: 2974771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventilatory dysfunction precedes pulmonary vascular changes in monocrotaline-treated rats.
    Lai YL; Olson JW; Gillespie MN
    J Appl Physiol (1985); 1991 Feb; 70(2):561-6. PubMed ID: 1902454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of methylprednisolone on monocrotaline-induced pulmonary vascular disease and right ventricular hypertrophy.
    Langleben D; Reid LM
    Lab Invest; 1985 Mar; 52(3):298-303. PubMed ID: 3156262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycyrrhizin, inhibitor of high mobility group box-1, attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling in rats.
    Yang PS; Kim DH; Lee YJ; Lee SE; Kang WJ; Chang HJ; Shin JS
    Respir Res; 2014 Nov; 15():148. PubMed ID: 25420924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-Methoxyestradiol mediates the protective effects of estradiol in monocrotaline-induced pulmonary hypertension.
    Tofovic SP; Zhang X; Jackson EK; Dacic S; Petrusevska G
    Vascul Pharmacol; 2006 Dec; 45(6):358-67. PubMed ID: 16872912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genistein, a phytoestrogen, attenuates monocrotaline-induced pulmonary hypertension.
    Homma N; Morio Y; Takahashi H; Yamamoto A; Suzuki T; Sato K; Muramatsu M; Fukuchi Y
    Respiration; 2006; 73(1):105-12. PubMed ID: 16432296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of leukotriene B4 in monocrotaline-induced pulmonary hypertension].
    Tabata T; Ono S; Song C; Noda M; Suzuki S; Tanita T; Fujimura S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Feb; 35(2):160-6. PubMed ID: 9103852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary restriction, polyamines and monocrotaline-induced pulmonary hypertension.
    Hacker AD
    Biochem Pharmacol; 1993 Jun; 45(12):2475-81. PubMed ID: 8328985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of deoxyribonucleic acid synthesis by difluoromethylornithine. Role of polyamine metabolism in monocrotaline-induced pulmonary hypertension.
    Hacker AD
    Biochem Pharmacol; 1992 Sep; 44(5):965-71. PubMed ID: 1530663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exaggerated pulmonary hypertension with monocrotaline in rats susceptible to chronic mountain sickness.
    Colice GL; Hill N; Lee YJ; Du H; Klinger J; Leiter JC; Ou LC
    J Appl Physiol (1985); 1997 Jul; 83(1):25-31. PubMed ID: 9216940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of various doses of monocrotaline administration on the development of pulmonary hypertension and its regression in rats].
    Kakusaka I; Kaneko N; Kiyatake K; Fujita A; Suzuki A; Nakano K; Okada O; Sugita T; Watanabe S; Kuriyama T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jan; 27(1):51-6. PubMed ID: 2501548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvia Miltiorrhiza Bge.f.alba Ameliorates the Progression of Monocrotaline-Induced Pulmonary Hypertension by Protecting Endothelial Injury in Rats.
    Wang Y; Cao SH; Cui YJ; Kong LK; Tian H; Cai HX; Wu YP; Han JJ; Zhao XM; Xia ZL
    Tohoku J Exp Med; 2015 Jun; 236(2):155-62. PubMed ID: 26074502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung vessel leak precedes right ventricular hypertrophy in monocrotaline-treated rats.
    Sugita T; Hyers TM; Dauber IM; Wagner WW; McMurtry IF; Reeves JT
    J Appl Physiol Respir Environ Exerc Physiol; 1983 Feb; 54(2):371-4. PubMed ID: 6219974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polyamine synthesis blockade in monocrotaline-induced pneumotoxicity.
    Olson JW; Orlinska U; Gillespie MN
    Biochem Pharmacol; 1989 Sep; 38(17):2903-10. PubMed ID: 2505777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.